Director
Eli Lilly and Company
Indianapolis, Indiana
Siyuan Huang is a pharmaceutical scientist with broad experience across the spectrum of drug development, ranging from pre-clinical development, prototyping formulation, to commercial manufacturing tech transfer, and New Drug Application submission. He is currently serving as Formulation Director in Small Molecule Design and Development department at Eli Lilly and Company. Siyuan possesses over 7 years of specialized industrial expertise in oral peptide delivery formulation design/development as well as small molecule formulation/process optimization. Prior to joining Lilly, Siyuan received his Ph.D. from the department of Molecular Pharmaceutics & Drug Delivery at the University of Texas at Austin in 2017. His doctoral research concentrated on advancing process and formulation optimization of hot-melt extrusion technique, notably through the application in amorphous solid dispersions for thermally labile drugs. Siyuan has contributed to over 30 peer-reviewed research articles, reviews, abstracts, patents and patent applications, and book chapters.
Disclosure information not submitted.
Impact of Absorption Region on Permeation Enhancer-Based Oral Peptide Delivery System: A Case Study
Monday, October 21, 2024
4:10 PM – 4:30 PM MT